Our results revealed that GS-A patients displayed the most favorable prognosis, which were characterized by a high mutation rate of genes including IDH1, ATRX and EGFR. Previously published reports indicated that IDH, ATRX and EGFR mutation status significantly influenced the prognosis of glioma patients (39). Here, ATRX is linked to glioma.